Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2da, no need to get sidetracked. for me, its about recouping as much of the money lost. couldn't care less what the m.b. relatives say, unless its a factual article about ariad. having said that, do you have a theory for the ascending share price? may there be discussions going on at ariad that point to a for sale sign? for a company with the goods, but strapped with money issues, what other logic could cause a steady price increase?
when were you accused of being of posting on behalf of others. Please reference any post saying anything of the kind.
Ask your self this, are posters that do not take their financial risks serious, really invested?
Harvey is a sneaky player. Should share more
Isider buying is good. Doubt hes buying at these prices now, for further near term dilution. If Harvey knows one thing its capitalizing on making money at the right time (b/o on the horizon?) Financial logic for the company starting to take place? Let's hope so
I agree with the B/O. Seems like that would be a win for everyone involved, including the pipeline.
"Until Ariad solves the cash crisis,"
what do you think their best (or only?) course of action should be for these pipeline approvals/indications to emerge on the market.
Because Overall market up? Or news/speculation looming?
This deal makes great financial sense for harvey. Consider you have limited cash on hand and possibly little time left as ceo. sell what assets you have now (in this case, your stake in bellicum) for $50m and Pocket what you can. Then turn around and sell the rest of the company and make millions more. then call it a career. If one thing is clear, harvey is all about himself first.
As an investor of ariad, that is definitely a concern to keep an eye on moving forward. Need to look at all the variables in order to succeed when investing. Fool me once, shame on you...
Burger has got to go.
Financial logic will prevail
its up to the companies that so choose, to make a living trying to save lives. its up to savy "investors" to try and make money from those companies success or mistakes on trying to save lives.
last i checked, i don't work for ariad...ariad works for me.
Never said i was any better...yet
Not savy enough of an investor to do more than just buy and hold. If i could, i would not be here. The Board does produce articles and facts, With some unbiased thoughts sprinkled on top. I form my own stratageis and opinion from those pieces. Thats why i maintain that financial logic will prevail at ariad
Lol, Thanks for the education? Unfortunately, Not in it for the message board. Continuous bashing or pumping does not make one any more wealth. Facts, professional sentiments and unbiased strategies, are what drive successful investments
Lol, Thanks for the encouragement and concern? Lol...But as my post states, strangers on message boards do not sway my hand one way or the other. Nice try though.
Wish i could. Like it or not, it's all about the money for me...not about strangers on message boards. To each their own
Let me get this straight, the message board bashes someone because they may be shorting the stock, hence making more money than longs up to this point. then switch to a long play for more capitalization?...Brilliant!
Hell, i wish i were a more savy investor to be able to strategize such a play.
bash away...Making MONEY is the name of this game. kudos to who can pull this off.
Well, considering biotech is a risky investment, even for insiders, these purchases are telling. Success for all indications is a ways off. Also, even after months/years of research, success is still not a given, with the fda having the final say.
These monthly share purchases could indicate an insider knowledge of not wanting to miss out on a more realistic opportunity. An opportunity that the company may now be considering and reveal 1st half of next year?
Financial logic should prevail for ariad
It may be taking a little time, but rest assure, denners presence is having an affect on team ariad. A savvy investor as denner on the board, cannot be ignored. Financial logic will prevail.
the second half of your post was reasonable, but shorter versions were already stated:
post 55743
different indications for their science are there. unfortunately, ariad is still a small player in the field, with financial limitation. being able to move those indications forward, without diluting the share price any further, is a concerning obstacle. I'm sure the higher ups are aware of that financial burden. logic should prevail.
or post 55754
with a good financial backing, ariads potential pipeline is attractive. hopefully, one of these mornings the headlines will read that a major player in the pharmaceutical field, has approached ariad as an interested party. don't even need the buyout headline. the interested party headline alone, will get this stock moving in the right direction. hope you get the math, harvey!...financial logic should prevail.
or post 55800
"very egotistical and hard headed person", might be putting it lightly. in the next few months, there will be ongoing discussions behind the scenes solely directed towards the future of ariad. if harvey continues to be exposed by choosing his power monger status, over reasonable and financially sound outcomes for the company, there will most certain be a rift between him and his cohorts. and unlike the last backlash of directors, at this stage of the game, another internal rift may be to great for the ceo to successfully over come, if he ends up on top. financial logic for all invested parties should prevail.
etc.
forget the silliness of the m.b.…financial logic should prevail
As i have been stating, time and money are not on ariads side. Harvey's stand alone concept, with him as its caligula Caesar figure, will surely not pass blindly by. Especially with such an orpatune investor on the board. Financial logic should prevail.
With its remaining funds, i believe the company is now positioning itself towards the best possible buyout offer.
When run efficiently, ariads pipeline has the opportunity to generate a lucrative investment for a big player. Denner knows this, and other higher ups should be getting on board. With time and money being ariads biggest hurdles, Financial logic should prevail.
spot on! before last years crash, hb stated (fox business interview), the companies future depends on the success of pona. unfortunately, all did not go as planned for pona's success. ariad is now a billion dollar company at only $5+ a share. how does a company in ariad's situation, continue to further develop a potentially great pipeline with limited funding?
when there is money involved, even the current BODs (or yes puppets), can become disgruntled. that is why i believe financial logic will prevail.
The company, including stock price, will not see prominent gains staying the course. A major shake up needs to take place for future success on all fronts. Harvey cannot continue down this high risk path, just for the sake of staying on as ceo. Financial logic should prevail at some point 1st 1/2 2015.
"very egotistical and hard headed person", might be putting it lightly. in the next few months, there will be ongoing discussions behind the scenes solely directed towards the future of ariad. if harvey continues to be exposed by choosing his power monger status, over reasonable and financially sound outcomes for the company, there will most certain be a rift between him and his cohorts. and unlike the last backlash of directors, at this stage of the game, another internal rift may be to great for the ceo to successfully over come, if he ends up on top. financial logic for all invested parties should prevail.
with a good financial backing, ariads potential pipeline is attractive. hopefully, one of these mornings the headlines will read that a major player in the pharmaceutical field, has approached ariad as an interested party. don't even need the buyout headline. the interested party headline alone, will get this stock moving in the right direction. hope you get the math, harvey!...financial logic should prevail.
different indications for their science are there. unfortunately, ariad is still a small player in the field, with financial limitation. being able to move those indications forward, without diluting the share price any further, is a concerning obstacle. I'm sure the higher ups are aware of that financial burden. logic should prevail.
the markets are hitting all time highs. ariad has recently posted encouraging news. yet, the stock has struggled to make it out of the $5 range. i believe this upward struggle in share price, is due in part because of the ceo, or "harvey effect". as more promising potential for the science surfaces, financial logic should prevail moving forward.
with the markets hitting all time highs + recent promising news coming out concerning ariads science, the the stock has struggled to make it out of the $5 range. i believe this upward struggle in share price, is due in part because of the ceo, or "harvey effect". as more promising potential for the science surfaces, financial logic should prevail moving forward.
For ariads goods to mature for those in need and for investors, logic should prevail. a buyout, or harvey having a diminished role, will make the most humane and financial sense.
The science is there. Hopefully the management team at ariad is in the process to unlock the greatest return for investors and patients from that science.
Merck just received breakthrough status for their lung cancer treatment keytruda. With mercks unhindered funding, Can this harm ariads success with 113 moving forward?
at some point early next year, logic should prevail on whats best for the company moving forward. being on a board has special comps, like being a part of an exclusive country club. this bodes well for stragglers living the life. the problem with living that life is ultimately the amount of money one can extract from that exclusive club. thats where that exclusive living takes a twist. up until the crash last year, these board members, plus higher ups were content with the direction of the company.
one year latter, the bad karma surrounding the company and more so to its ceo, is with out question hindering on that flow of success. if in the next 2-4 months as more positive news comes to the fore front, and the share price does not react in accordance to those positive events, logic should come into play. throw in some board members that are in it strictly for the investment to strongly voice their opinion on the matter. a shift in pressure to sell could become apparent.
does it make sense for the majority that have a large stake in the company not named harvey, to continue and dilute, waiting years on the share price to maybe reach $20? or wait less than a year to possibly reach, or exceed that price in a buyout? in the end, money talks. JMPOM
"What makes the whole situation unpredictable is that if mN is promising,"
True, yet the real unpredictable situation is harvey. at his age, does he really want to to scrap the discoveries up to this point to start at a beginning with mN. taking more years to develop, with an uncertain outcome? what would that do for him? why with his wealth, would he want to continue logging in starting point hours? if he continues to try and dilute the company further, just for sake of not wanting to enjoy the greener pastures of his wealth at home, wouldn't the board and other higher ups see this as a reason for his dismissal? at harvs age, one has to be aware of his actions contributing to the companies health or his own personal agenda.
i do not believe denner is in it for harveys longevity. it would not be in an investors best interest to put money on a 60 plus year olds train of thinking, to get you to the promise land. the company has stalled for this reason alone (antiquated thinking). further dilution will put years on the companies development, being run by a 70 plus year old. no, i do not think denner, and any real investor want to see that taking place.
at some point, no matter where the share price is or what company you are, a buyout is always beneficial to the increase of that companys wealth. hopefully, ariads cohorts are starting to realize the time is coming to move away as a stand alone.
2da's posts are informative and realistic in terms of investing decisions and the company's future. stubborn as he may well be, there is no way the harv, or any of his cronies, or denner, doesn't see the situation of the company as 2da does. would hate to think the harv has lost his sense of reality with the situation (aka. one flew over the cuckoos nest). there have been some minor positive news about ariads progress that have come out these past few months, that can also help benefit a large bios portfolio if successful. those positives plus Mn can also lead to a more decent bid for a BO within the next year. with that in mind (and hoping the harv does have some sense of reality left), i continue to hold for the greater good that these drugs get the ability to mature through a well financed pharmaceutical company, which in turn will benefit the longs who have endured.
the science has never been in question. the concern is how the management team has gone about to develop and bring that science to the market, for a more profitable return.
if the company succeeds and the stock price climbs, the thought for true longs will always be a: we should've gotten there sooner and b: the stock price could've been higher.
i remember sometime ago ( i believe a few months before ponatinib approval), the harv was giving a tv interview to fox business with liz claman. in that interview he stated that ariads future undoubtedly lies with the approval and maturation of ponatinib. one year later, the crash occurred. as in harveys own words, ariads future came into doubt. skip to the present day and ariad is now functioning on borrowed time. the company has the goods, but not enough left in the tank for full development of those goods. a buyout is the reasonable option, because as the ceo harv stated, without ponas success, its unlikely for a prosperous future.
Wow, the potential these drugs would have to a company with deep pockets. Positive signs for a buyout.